Philip Morris (PM) Q1 2024 Earnings Report

PM delivered a strong start to 2024 with double-digit gains in organic revenue and operating income, supported by continued momentum in its smoke-free platform. In Q1, organic net revenue rose 11.0% (8.6% including currency), led by IQOS and ZYN, while HTU volumes and ZYN mix drove gross profit growth. The period featured a notable margin expansion: organic operating income margins rose 370 basis points, with smoke-free gross margins up around 600 basis points on an organic basis. Management attributed much of the outperformance to higher volumes, strategic pricing actions to offset currency headwinds (notably Egyptian pound devaluation), and productivity improvements in manufacturing and SG&A. The company raised its currency-neutral growth outlook for 2024 and provided dollar-term guidance, signaling confidence in translating top-line momentum into earnings despite ongoing FX headwinds.

PM emphasized a disciplined prioritization of growth investments and cost efficiencies to protect margins, while continuing to scale its smoke-free platform (IQOS ILUMA, ZYN, VEEV) and expand into new markets (Indonesia, Japan, Europe, and others). The balance sheet remains heavily leveraged, with net debt to adjusted EBITDA targeted to improve meaningfully in 2024 and a plan to reach around 2x debt by end-2026. The strategic narrative remains the pursuit of a substantially smoke-free future by 2030, supported by sustainability initiatives and governance improvements.

Overall, the Q1 performance reinforces a constructive view on the company’s ability to grow in its core smoke-free categories, but investors should monitor FX headwinds, deleveraging trajectory, and the pace of expansion into newer markets and product formats that underpin PM’s longer-term revenue mix and margin profile.